menu search

Saratoga: well diversified bdc but has an overstretched payout ratio

SAR had a record year with exceptional AUM and Nii growth. The management has launched a new dividend s...

December 11, 2021, 10:59 pm

Saratoga: well diversified bdc but has an overstretched payout ratio

SAR had a record year with exceptional AUM and Nii growth. The management has launched a new dividend s...

December 11, 2021, 10:59 pm

Getty images announces spac deal, talks nft plans for growth: what investors should know

Content creator and image marketplace Getty Images announced a SPAC deal with CC Neuberger Principal Holdings ...

December 11, 2021, 7:53 am

Getty images announces spac deal, talks nft plans for growth: what investors should know

Content creator and image marketplace Getty Images announced a SPAC deal with CC Neuberger Principal Holdings ...

December 11, 2021, 7:53 am

Getty images announces spac deal, talks nft plans for growth: what investors should know

Content creator and image marketplace Getty Images announced a SPAC deal with CC Neuberger Principal Holdings ...

December 11, 2021, 7:53 am

Steppe gold gets price target raised to $3.50 by stifel after positive feasibility study report on phase ii sulphide expansion

Stifel Financial Corp has increased its price target for Steppe Gold Limited (TSX:STGO, OTCQX:STPGF) to $3.50 from $1.90 and repeated a 'Buy' rating o...

December 7, 2021, 12:54 pm

Steppe gold gets price target raised to $3.50 by stifel after positive feasibility study report on phase ii sulphide expansion

Stifel Financial Corp has increased its price target for Steppe Gold Limited (TSX:STGO, OTCQX:STPGF) to $3.50 from $1.90 and repeated a 'Buy' rating o...

December 7, 2021, 12:54 pm

Steppe gold gets price target raised to $3.50 by stifel after positive feasibility study report on phase ii sulphide expansion

Stifel Financial Corp has increased its price target for Steppe Gold Limited (TSX:STGO, OTCQX:STPGF) to $3.50 from $1.90 and repeated a 'Buy' rating o...

December 7, 2021, 12:54 pm

Hawaiian airlines ceo says omicron variant has pushed back travel recovery

The reaction by international governments to the Omicron variant of COVID-19 has pushed back the timing a travel recovery, the chief executive of Hawa...

December 6, 2021, 9:40 pm

Hawaiian airlines ceo says omicron variant has pushed back travel recovery

The reaction by international governments to the Omicron variant of COVID-19 has pushed back the timing a travel recovery, the chief executive of Hawa...

December 6, 2021, 9:40 pm

Hawaiian airlines ceo says omicron variant has pushed back travel recovery

The reaction by international governments to the Omicron variant of COVID-19 has pushed back the timing a travel recovery, the chief executive of Hawa...

December 6, 2021, 9:40 pm

Bayer's (bayry) phase iii study on nubeqa combo meets goal

Bayer's (BAYRY) phase iiI study evaluating Nubeqa in combination with docetaxel and androgen deprivatio...

December 6, 2021, 1:50 pm

Bayer's (bayry) phase iii study on nubeqa combo meets goal

Bayer's (BAYRY) phase iiI study evaluating Nubeqa in combination with docetaxel and androgen deprivatio...

December 6, 2021, 1:50 pm

Bayer's (bayry) phase iii study on nubeqa combo meets goal

Bayer's (BAYRY) phase iiI study evaluating Nubeqa in combination with docetaxel and androgen deprivatio...

December 6, 2021, 1:50 pm

The burger king capitals of america

The Burger King Capitals of America – 24/7 Wall St. var __wallst_pii_detected = __wallst_p...

December 4, 2021, 9:00 am

The burger king capitals of america

The Burger King Capitals of America – 24/7 Wall St. var __wallst_pii_detected = __wallst_p...

December 4, 2021, 9:00 am

The burger king capitals of america

The Burger King Capitals of America – 24/7 Wall St. var __wallst_pii_detected = __wallst_p...

December 4, 2021, 9:00 am

Biogen loses bid to revive tecfidera drug patent: bloomberg

Biogen Inc (NASDAQ: BiiB) lost its appeals court bid to revive a key patent on the blockbuster multipl...

November 30, 2021, 1:13 pm

Biogen loses bid to revive tecfidera drug patent: bloomberg

Biogen Inc (NASDAQ: BiiB) lost its appeals court bid to revive a key patent on the blockbuster multipl...

November 30, 2021, 1:13 pm

Biogen loses bid to revive tecfidera drug patent: bloomberg

Biogen Inc (NASDAQ: BiiB) lost its appeals court bid to revive a key patent on the blockbuster multipl...

November 30, 2021, 1:13 pm


Search within

Pages Search Results: